Erasca, Inc. SEC filings ERAS

Erasca, Inc. has 352 filings in SEC EDGAR's recent list, going back to Jan 15, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.

Erasca, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 16, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
8-K Current report
Other events
Aug 24, 2026 Aug 24, 2026
144 Notice of proposed sale Aug 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
3 Initial insider ownership Aug 12, 2026 Aug 10, 2026
S-8 Employee stock plan registration Aug 11, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Officer or director change
Aug 10, 2026 Aug 10, 2026
144 Notice of proposed sale Jul 21, 2026 —
8-K Current report
Other events
Jul 14, 2026 Jul 13, 2026
424B5 Prospectus supplement Jul 14, 2026 —
424B5 Prospectus supplement Jul 13, 2026 —
8-K Current report
Other events
Jul 13, 2026 Jul 13, 2026
S-3ASR Automatic shelf registration Jul 13, 2026 —
8-K Current report
Shareholder vote results
Jul 1, 2026 Jun 26, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2026 —
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 26, 2026
8-K Current report
Other events
Apr 27, 2026 Apr 27, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 27, 2026 Apr 27, 2026
8-K Current report
Other events
Apr 21, 2026 Apr 21, 2026
144/A Filing Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
144 Notice of proposed sale Mar 16, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Jan 30, 2026 Jan 29, 2026
4 Insider transaction Jan 30, 2026 Dec 15, 2025
4 Insider transaction Jan 30, 2026 Jan 29, 2026
4 Insider transaction Jan 30, 2026 Jan 29, 2026
4 Insider transaction Jan 30, 2026 Jan 29, 2026
8-K Current report
Other events
Jan 29, 2026 Jan 29, 2026
8-K Current report
Other events
Jan 22, 2026 Jan 21, 2026
424B5 Prospectus supplement Jan 22, 2026 —
8-K Current report
Results of operations
Jan 20, 2026 Jan 20, 2026
424B5 Prospectus supplement Jan 20, 2026 —
144 Notice of proposed sale Jan 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 14, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 8, 2026 Dec 15, 2025
144 Notice of proposed sale Jan 7, 2026 —
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
144 Notice of proposed sale Oct 15, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
EFFECT Filing Aug 22, 2025 —
CORRESP Letter to the SEC Aug 20, 2025 —
UPLOAD Letter from the SEC Aug 18, 2025 —
144 Notice of proposed sale Aug 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2025 —
S-3 Shelf registration Aug 12, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
144 Notice of proposed sale Jul 15, 2025 —
8-K Current report
Shareholder vote results
Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
144 Notice of proposed sale Jun 16, 2025 —
4 Insider transaction Jun 3, 2025 May 23, 2025
144 Notice of proposed sale May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 24, 2025
144 Notice of proposed sale Apr 15, 2025 —
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
144 Notice of proposed sale Mar 17, 2025 —
144 Notice of proposed sale Feb 18, 2025 —
4 Insider transaction Feb 18, 2025 Feb 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
144 Notice of proposed sale Jan 15, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
144 Notice of proposed sale Dec 16, 2024 —
144 Notice of proposed sale Nov 15, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 29, 2024 —
SC 13G Ownership over 5% (passive) Oct 24, 2024 —
8-K Current report
Other events
Oct 24, 2024 Oct 24, 2024
144 Notice of proposed sale Oct 15, 2024 —
144 Notice of proposed sale Sep 16, 2024 —
144 Notice of proposed sale Aug 15, 2024 —
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
144 Notice of proposed sale Jul 15, 2024 —
8-K Current report
Shareholder vote results
Jun 24, 2024 Jun 20, 2024
8-K Current report
Other events
Jun 24, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
144 Notice of proposed sale Jun 17, 2024 —
SC 13G Ownership over 5% (passive) May 31, 2024 —
SC 13G Ownership over 5% (passive) May 29, 2024 —
SC 13G Ownership over 5% (passive) May 28, 2024 —
4 Insider transaction May 22, 2024 May 21, 2024
424B5 Prospectus supplement May 17, 2024 —
8-K Current report
Other events
May 17, 2024 May 16, 2024
EFFECT Filing May 16, 2024 —
8-K Current report
Material agreement, Exit or restructuring costs, Other events
May 16, 2024 May 14, 2024
144 Notice of proposed sale May 15, 2024 —
CORRESP Letter to the SEC May 14, 2024 —
UPLOAD Letter from the SEC May 14, 2024 —
S-3 Shelf registration May 9, 2024 —
S-8 Employee stock plan registration May 9, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 20, 2024
144 Notice of proposed sale Apr 15, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 28, 2024 Mar 27, 2024
10-K Annual report Mar 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
144 Notice of proposed sale Mar 15, 2024 —
144 Notice of proposed sale Feb 15, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 7, 2024 Feb 5, 2024
4 Insider transaction Feb 7, 2024 Feb 5, 2024
4 Insider transaction Feb 7, 2024 Feb 5, 2024
4 Insider transaction Feb 7, 2024 Feb 5, 2024
SC 13D/A Amended ownership over 5% (active) Jan 30, 2024 —
144 Notice of proposed sale Jan 16, 2024 —
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Dec 18, 2023 Dec 15, 2023
4 Insider transaction Dec 18, 2023 Dec 15, 2023
144 Notice of proposed sale Dec 15, 2023 —
8-K Current report
Other events
Dec 11, 2023 Dec 11, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 6, 2023 Dec 5, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ERAS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
, Emerging growth company
SEC CIK
1761918

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.